GRFS vs. MIRA
GRFS (Grifols, S.A.) and MIRA (MIRA Pharmaceuticals Inc. Common Stock) are both stocks. Both operate in the Drug Manufacturers - General industry within the Healthcare sector. Over the past year, GRFS returned -15.59% vs -22.01% for MIRA. At a 0.10 correlation, their price movements are largely independent.
Performance
GRFS vs. MIRA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GRFS achieves a -22.14% return, which is significantly higher than MIRA's -36.99% return.
GRFS
- 1D
- -1.62%
- 1M
- -8.77%
- YTD
- -22.14%
- 6M
- -19.82%
- 1Y
- -15.59%
- 3Y*
- -6.06%
- 5Y*
- -15.65%
- 10Y*
- -6.28%
MIRA
- 1D
- -0.09%
- 1M
- -4.08%
- YTD
- -36.99%
- 6M
- -38.21%
- 1Y
- -22.01%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
GRFS vs. MIRA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
GRFS Grifols, S.A. | -22.14% | 27.79% | -35.64% | 14.46% |
MIRA MIRA Pharmaceuticals Inc. Common Stock | -36.99% | 32.46% | 8.57% | -85.00% |
Correlation
The correlation between GRFS and MIRA is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Aug 3, 2023 | 0.10 |
The correlation between GRFS and MIRA shifts across timeframes, from 0.10 (all time) to 0.20 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
GRFS:
€0.61
MIRA:
-$1.57
GRFS:
€7.45B
MIRA:
$0.00
GRFS:
€2.81B
MIRA:
$0.00
GRFS:
€1.56B
MIRA:
-$6.93M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GRFS vs. MIRA — Risk / Return Rank
GRFS
MIRA
GRFS vs. MIRA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Grifols, S.A. (GRFS) and MIRA Pharmaceuticals Inc. Common Stock (MIRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GRFS | MIRA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.21 | ||
| Sortino ratioReturn per unit of downside risk | -0.61 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 1.01 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | -0.49 | -0.41 | -0.08 |
| Martin ratioReturn relative to average drawdown | -0.89 | -0.62 | -0.27 |
Loading charts...
Drawdowns
GRFS vs. MIRA - Drawdown Comparison
The maximum GRFS drawdown since its inception was -78.01%, smaller than the maximum MIRA drawdown of -92.69%. Use the drawdown chart below to compare losses from any high point for GRFS and MIRA.
Loading charts...
Drawdown Indicators
| GRFS | MIRA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.01% | -92.69% | +14.68% |
Max Drawdown (1Y)Largest decline over 1 year | -32.22% | -54.46% | +22.24% |
Max Drawdown (3Y)Largest decline over 3 years | -52.68% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -69.29% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -78.01% | — | — |
Current DrawdownCurrent decline from peak | -70.24% | -87.18% | +16.94% |
Average DrawdownAverage peak-to-trough decline | -31.83% | -78.41% | +46.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.58% | 35.69% | -18.11% |
Volatility
GRFS vs. MIRA - Volatility Comparison
The current volatility for Grifols, S.A. (GRFS) is 6.88%, while MIRA Pharmaceuticals Inc. Common Stock (MIRA) has a volatility of 21.72%. This indicates that GRFS experiences smaller price fluctuations and is considered to be less risky than MIRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GRFS | MIRA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.88% | 21.72% | -14.84% |
Volatility (6M)Calculated over the trailing 6-month period | 24.38% | 46.64% | -22.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.82% | 79.35% | -47.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.78% | 392.43% | -343.65% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 40.32% | 392.43% | -352.11% |
Dividends
GRFS vs. MIRA - Dividend Comparison
GRFS's dividend yield for the trailing twelve months is around 2.41%, while MIRA has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GRFS Grifols, S.A. | 2.41% | 1.88% | 0.00% | 0.00% | 0.00% | 3.20% | 0.83% | 1.55% | 2.32% | 1.24% | 1.67% | 2.01% |
MIRA MIRA Pharmaceuticals Inc. Common Stock | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
GRFS vs. MIRA - Financials Comparison
This section allows you to compare key financial metrics between Grifols, S.A. and MIRA Pharmaceuticals Inc. Common Stock. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
GRFS and MIRA have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MIRA has higher volatility (21.72%) compared to GRFS (6.88%). In terms of maximum drawdown, GRFS dropped -78.01% vs MIRA's -92.69%.
MIRA currently has the higher Sharpe Ratio (-0.28 vs -0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GRFS and MIRA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer